Gilead Relinquishes Its PrEP Patent—But Did It Mislead Investors? – Filter

10th May 2019

Gilead Relinquishes Its PrEP Patent—But Did It Mislead Investors? Filter

On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive patent on Truvada for HIV pre-exposure prophylaxis (PrEP), the …